Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 6/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.48 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7956634 | 0.97 | P2RX7 (0.72) | P2RX7ABCB11EPHX2GPR55 | |
| SCHEMBL6939407 | 0.88 | P2RX7 (0.72) | P2RX7ABCB11EPHX2 | |
| Hydrochloric Acid SCHEMBL6943149 | 0.88 | P2RX7 (0.71) | P2RX7ABCB11EPHX2 | |
| SCHEMBL7955732 | 0.87 | P2RX7 (0.70) | P2RX7ABCB11EPHX2 | |
| SCHEMBL6943104 | 0.84 | P2RX7 (0.76) | P2RX7ABCB11 | |
| SCHEMBL6860227 | 0.83 | P2RX7 (1.00) | P2RX7ABCB11 | |
| SCHEMBL7965380 | 0.79 | P2RX7 (0.71) | P2RX7EPHX2GPR55 | |
| SCHEMBL6939404 | 0.77 | P2RX7 (0.72) | P2RX7ABCB11GPR55 | |
| SCHEMBL7661587 | 0.76 | P2RX7 (0.70) | P2RX7ABCB11EPHX2 | |
| SCHEMBL6941247 | 0.75 | P2RX7 (0.69) | P2RX7ABCB11GPR55 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6242470-B1 | RHEUMATIC DISEASES; ANTIARTHRITIC AGENTS, ANTIALLERGENS; IRRITABLE BOWEL SYNDROME; AMIDATION | ASTRAZENECA AB (SE) | 2001-06-05 | — | — | US | claimed |
| US-6242470-B1 | RHEUMATIC DISEASES; ANTIARTHRITIC AGENTS, ANTIALLERGENS; IRRITABLE BOWEL SYNDROME; AMIDATION | ASTRAZENECA AB (SE) | 2001-06-05 | — | — | US | disclosed |